WO2001060826A3 - SUCCINOYLAMINO CARBOCYCLES AND HETEROCYCLES AS INHIBITORS OF Aβ PROTEIN PRODUCTION - Google Patents
SUCCINOYLAMINO CARBOCYCLES AND HETEROCYCLES AS INHIBITORS OF Aβ PROTEIN PRODUCTION Download PDFInfo
- Publication number
- WO2001060826A3 WO2001060826A3 PCT/US2001/005236 US0105236W WO0160826A3 WO 2001060826 A3 WO2001060826 A3 WO 2001060826A3 US 0105236 W US0105236 W US 0105236W WO 0160826 A3 WO0160826 A3 WO 0160826A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- carbocycles
- heterocycles
- succinoylamino
- inhibitors
- protein production
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
- C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
- C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
- C07D243/24—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/06—Peri-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/06—Peri-condensed systems
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001560210A JP2003523345A (en) | 2000-02-17 | 2001-02-16 | Succinoylamino carbocycles and heterocycles as inhibitors of Aβ protein production |
CA002395862A CA2395862A1 (en) | 2000-02-17 | 2001-02-16 | Succinoylamino carbocycles and heterocycles as inhibitors of a.beta. protein production |
EP01914400A EP1261610A2 (en) | 2000-02-17 | 2001-02-16 | Succinoylamino carbocycles and heterocycles as inhibitors of a-beta protein production |
AU2001239791A AU2001239791A1 (en) | 2000-02-17 | 2001-02-16 | Succinoylamino carbocycles and heterocycles as inhibitors of abeta protein production |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US18318600P | 2000-02-17 | 2000-02-17 | |
US60/183,186 | 2000-02-17 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2001060826A2 WO2001060826A2 (en) | 2001-08-23 |
WO2001060826A3 true WO2001060826A3 (en) | 2002-01-17 |
Family
ID=22671796
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2001/005236 WO2001060826A2 (en) | 2000-02-17 | 2001-02-16 | SUCCINOYLAMINO CARBOCYCLES AND HETEROCYCLES AS INHIBITORS OF Aβ PROTEIN PRODUCTION |
Country Status (6)
Country | Link |
---|---|
US (1) | US6525044B2 (en) |
EP (1) | EP1261610A2 (en) |
JP (1) | JP2003523345A (en) |
AU (1) | AU2001239791A1 (en) |
CA (1) | CA2395862A1 (en) |
WO (1) | WO2001060826A2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9139520B2 (en) | 2007-12-21 | 2015-09-22 | Ligand Pharmaceuticals Incorporated | Selective androgen receptor modulators (SARMs) and uses thereof |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL142816A0 (en) | 1998-12-24 | 2002-03-10 | Du Pont Pharm Co | SUCCINOYLAMINO BENZODIAZEPINES AS INHIBITORS OF Aβ PROTEIN PRODUCTION |
US6525044B2 (en) | 2000-02-17 | 2003-02-25 | Bristol-Myers Squibb Company | Succinoylamino carbocycles and heterocycles as inhibitors of a-β protein production |
CA2403550A1 (en) | 2000-04-03 | 2001-10-11 | Hong Liu | Cyclic lactams as inhibitors of a-.beta. protein production |
US7146209B2 (en) * | 2000-05-08 | 2006-12-05 | Brainsgate, Ltd. | Stimulation for treating eye pathologies |
US6878363B2 (en) | 2000-05-17 | 2005-04-12 | Bristol-Myers Squibb Pharma Company | Use of small molecule radioligands to discover inhibitors of amyloid-beta peptide production and for diagnostic imaging |
US6509333B2 (en) * | 2000-06-01 | 2003-01-21 | Bristol-Myers Squibb Pharma Company | Lactams substituted by cyclic succinates as inhibitors of Aβ protein production |
RU2304140C2 (en) * | 2001-12-27 | 2007-08-10 | Дайити Фармасьютикал Ко., Лтд. | INHIBITORS FOR PRODUCING/SECRETION OF β-AMYLOID PROTEIN |
US20050266099A1 (en) * | 2002-04-25 | 2005-12-01 | Alon Shalev | Methods and apparatus for modifying properties of the bbb and cerebral circulation by using the neuroexcitatory and/or neuroinhibitory effects of odorants on nerves in the head |
US7684859B2 (en) * | 2002-04-25 | 2010-03-23 | Brainsgate Ltd. | Stimulation of the OTIC ganglion for treating medical conditions |
JP2006515999A (en) * | 2002-11-14 | 2006-06-15 | ブレインズゲート リミティド | Surgical tools and techniques for stimulation |
US8010189B2 (en) * | 2004-02-20 | 2011-08-30 | Brainsgate Ltd. | SPG stimulation for treating complications of subarachnoid hemorrhage |
US8055347B2 (en) | 2005-08-19 | 2011-11-08 | Brainsgate Ltd. | Stimulation for treating brain events and other conditions |
US9233245B2 (en) | 2004-02-20 | 2016-01-12 | Brainsgate Ltd. | SPG stimulation |
WO2006021957A2 (en) * | 2004-08-23 | 2006-03-02 | Brainsgate Ltd. | Concurrent bilateral spg modulation |
CA2635359A1 (en) * | 2005-12-29 | 2007-07-05 | Immupharma France Sa | Compositions and methods for synthesizing heterocyclic therapeutic compounds |
JP2009522234A (en) * | 2005-12-29 | 2009-06-11 | イミュファルマ・フランス・エスアー | Compositions and methods for inhibiting phospholipase A2 |
US20090210026A1 (en) * | 2006-08-17 | 2009-08-20 | Brainsgate Ltd. | Spg stimulation for enhancing neurogenesis and brain metabolism |
EP2121633A2 (en) | 2007-02-12 | 2009-11-25 | Merck & Co., Inc. | Piperazine derivatives for treatment of ad and related conditions |
CN101284828B (en) * | 2007-04-12 | 2011-04-27 | 中国科学院上海药物研究所 | Cycloheptapyridine compounds, preparation method thereof, use and pharmaceutical compositions containing the compounds |
US7860569B2 (en) | 2007-10-18 | 2010-12-28 | Brainsgate, Ltd. | Long-term SPG stimulation therapy for prevention of vascular dementia |
EP2291181B9 (en) | 2008-04-18 | 2013-09-11 | University College Dublin National University Of Ireland, Dublin | Captodiamine for the treatment of depression symptoms |
US20120142672A1 (en) | 2009-07-13 | 2012-06-07 | Tatsuki Koike | Heterocyclic compound and use thereof |
AR082865A1 (en) | 2010-09-02 | 2013-01-16 | Takeda Pharmaceutical | DERIVATIVES OF TRIAZOLO [4,3-A] PIRIDINA, AND ITS USES |
TWI530489B (en) | 2011-03-22 | 2016-04-21 | 必治妥美雅史谷比公司 | Bis(fluoroalkyl)-1,4-benzodiazepinone compounds |
GB201116559D0 (en) | 2011-09-26 | 2011-11-09 | Univ Leuven Kath | Novel viral replication inhibitors |
WO2014047374A1 (en) | 2012-09-21 | 2014-03-27 | Bristol-Myers Squibb Company | Alkyl, fluoroalkyl-1,4-benzodiazepinone compounds |
CN104822677A (en) | 2012-09-21 | 2015-08-05 | 百时美施贵宝公司 | Fluoroalkyl-1,4-benzodiazepinone compounds |
CN104854094A (en) | 2012-09-21 | 2015-08-19 | 百时美施贵宝公司 | Fluoroalkyl dibenzodiazepinone compounds |
CN104797569A (en) * | 2012-09-21 | 2015-07-22 | 百时美施贵宝公司 | Substituted 1,5-benzodiazepinone compounds |
US9249157B2 (en) | 2012-09-21 | 2016-02-02 | Bristol-Myers Squibb Company | Tricyclic heterocycle compounds |
TWI614238B (en) * | 2012-09-21 | 2018-02-11 | 必治妥美雅史谷比公司 | Bis(fluoroalkyl)-1,4-benzodiazepinone compounds and prodrugs thereof |
US9242940B2 (en) | 2012-09-21 | 2016-01-26 | Bristol-Myers Squibb Company | N-substituted bis(fluoroalkyl)-1,4-benzodiazepinone compounds |
EP2897942B1 (en) * | 2012-09-21 | 2016-08-31 | Bristol-Myers Squibb Company | Fluoroalkyl and fluorocycloalkyl 1,4-benzodiazepinone compounds as notch inhibitors |
EP2897941B1 (en) * | 2012-09-21 | 2016-09-07 | Bristol-Myers Squibb Company | Prodrugs of 1,4-benzodiazepinone compounds |
CN105101968A (en) | 2013-04-04 | 2015-11-25 | 百时美施贵宝公司 | Combination therapy for the treatment of proliferative diseases |
EP2878335B1 (en) | 2013-11-10 | 2018-01-03 | Brainsgate Ltd. | Implant and delivery system for neural stimulator |
EP3094323A4 (en) | 2014-01-17 | 2017-10-11 | Ligand Pharmaceuticals Incorporated | Methods and compositions for modulating hormone levels |
EP3093043B1 (en) | 2015-05-13 | 2018-11-14 | Brainsgate Ltd. | Implant and delivery system for neural stimulator |
Citations (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996029313A1 (en) * | 1995-03-21 | 1996-09-26 | The Procter & Gamble Company | Lactam-containing hydroxamic acid derivatives, their preparation and their use as inhibitors of matrix metalloprotease |
US5602156A (en) * | 1993-09-17 | 1997-02-11 | The United States Of America As Represented By The Department Of Health And Human Services | Method for inhibiting metalloproteinase expression |
WO1997012861A1 (en) * | 1995-10-05 | 1997-04-10 | Chiroscience Limited | Mercaptoamide derivatives and their therapeutic use |
US5703129A (en) * | 1996-09-30 | 1997-12-30 | Bristol-Myers Squibb Company | 5-amino-6-cyclohexyl-4-hydroxy-hexanamide derivatives as inhibitors of β-amyloid protein production |
US5770573A (en) * | 1993-12-06 | 1998-06-23 | Cytel Corporation | CS-1 peptidomimetics, compositions and methods of using the same |
WO1998028268A2 (en) * | 1996-12-23 | 1998-07-02 | Elan Pharmaceuticals, Inc. | CYCLOALKYL, LACTAM, LACTONE AND RELATED COMPOUNDS AS β-AMYLOID PEPTIDE RELEASE INHIBITORS |
WO1999032453A1 (en) * | 1997-12-22 | 1999-07-01 | Elan Pharmaceuticals, Inc. | POLYCYCLIC α-AMINO-⊂-CAPROLACTAMS AND RELATED COMPOUNDS |
WO1999052889A1 (en) * | 1998-04-10 | 1999-10-21 | Pfizer Products Inc. | (4-arylsulfonylamino)-tetrahydropyran-4-carboxylic acid hydroxamides |
US5985900A (en) * | 1997-04-01 | 1999-11-16 | Agouron Pharmaceuticals, Inc. | Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses |
WO1999067221A1 (en) * | 1998-06-22 | 1999-12-29 | Elan Pharmaceuticals, Inc. | Compounds for inhibiting beta-amyloid peptide release and/or its synthesis |
WO2000002903A1 (en) * | 1998-07-10 | 2000-01-20 | Cytel Corporation | Cs-1 peptidomimetics, compositions and methods of using the same |
WO2000007995A1 (en) * | 1998-08-07 | 2000-02-17 | Du Pont Pharmaceuticals Company | SUCCINOYLAMINO LACTAMS AS INHIBITORS OF Aβ PROTEIN PRODUCTION |
WO2000038618A2 (en) * | 1998-12-24 | 2000-07-06 | Du Pont Pharmaceuticals Company | SUCCINOYLAMINO BENZODIAZEPINES AS INHIBITORS OF Aβ PROTEIN PRODUCTION |
Family Cites Families (64)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2630440B1 (en) * | 1988-04-25 | 1991-09-20 | Jouveinal Sa | BENZODIAZEPINES, THEIR PREPARATION PROCESS AND INTERMEDIATES AND THEIR THERAPEUTIC APPLICATIONS |
ATE119040T1 (en) | 1989-08-04 | 1995-03-15 | Merck Sharp & Dohme | CENTRAL CHOLECYSTOKIN ANTAGONISTS FOR THE TREATMENT OF PSYCHIATRIC DISEASES. |
CA2026856A1 (en) | 1989-10-05 | 1991-04-06 | Mark G. Bock | 3-substituted-1,4-benzodiazepines useful as oxytocin |
CA2032427A1 (en) | 1989-12-18 | 1991-06-19 | Mark G. Bock | Benzodiazepines analogs |
GB9107368D0 (en) | 1991-04-08 | 1991-05-22 | Smithkline Beecham Plc | Novel compounds |
ES2163410T3 (en) | 1992-07-29 | 2002-02-01 | Merck Sharp & Dohme | DERIVATIVES OF BENZODIAZEPINA. |
US5283241A (en) | 1992-08-28 | 1994-02-01 | Merck & Co., Inc. | Benzo-fused lactams promote release of growth hormone |
NZ314922A (en) | 1992-12-21 | 1998-11-25 | Smithkline Beecham Corp | Benzodiazepinones; nitrogen containing heterocyclic intermediates and pharmaceutical compositions |
MX9308016A (en) | 1992-12-22 | 1994-08-31 | Lilly Co Eli | HUMAN IMMUNODEFICIENCY VIRUS PROTEASE INHIBITING COMPOUNDS, PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL FORMULATION CONTAINING THEM. |
WO1994026723A2 (en) | 1993-05-14 | 1994-11-24 | Genentech, Inc. | ras FARNESYL TRANSFERASE INHIBITORS |
WO1994029273A1 (en) | 1993-06-09 | 1994-12-22 | Smithkline Beecham Corporation | Bicyclic fibrinogen antagonists |
US5545735A (en) | 1993-10-04 | 1996-08-13 | Merck & Co., Inc. | Benzo-Fused Lactams promote release of growth hormone |
US5426185A (en) | 1993-11-22 | 1995-06-20 | Merck & Co., Inc. | Antiarrhythmic benzodiazepines |
US5763437A (en) | 1994-07-29 | 1998-06-09 | Fujisawa Pharmaceutical Co., Ltd. | Benzodiazepine derivatives |
US5661161A (en) | 1994-09-29 | 1997-08-26 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
EP0796252A4 (en) | 1994-12-09 | 1998-02-04 | Smithkline Beecham Corp | Bicyclic fibrinogen antagonists |
US5639746A (en) | 1994-12-29 | 1997-06-17 | The Procter & Gamble Company | Hydroxamic acid-containing inhibitors of matrix metalloproteases |
EP0799189A4 (en) | 1994-12-13 | 1999-03-17 | Smithkline Beecham Corp | Bicyclic fibrinogen antagonists |
US5578629A (en) | 1995-03-29 | 1996-11-26 | Merck & Co., Inc. | Benzamide-containing inhibitors of farnesyl-protein transferase |
US5856326A (en) | 1995-03-29 | 1999-01-05 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
GB9507799D0 (en) | 1995-04-18 | 1995-05-31 | British Biotech Pharm | Metalloproteinase inhibitors |
US5710171A (en) | 1995-05-24 | 1998-01-20 | Merck & Co., Inc. | Bisphenyl inhibitors of farnesyl-protein transferase |
MX9709278A (en) | 1995-05-29 | 1998-03-31 | Pfizer | Dipeptides which promote release of growth hormone. |
US5756528A (en) | 1995-06-06 | 1998-05-26 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
EP0761680A3 (en) | 1995-09-12 | 1999-05-06 | Ono Pharmaceutical Co., Ltd. | Tetrazole compounds having Interleukin-1beta converting enzyme inhibitory activity |
ATE205184T1 (en) | 1995-11-23 | 2001-09-15 | British Biotech Pharm | METALLOPROTEINASE INHIBITORS |
EP0944387A1 (en) | 1996-01-30 | 1999-09-29 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
US5919785A (en) | 1996-04-03 | 1999-07-06 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
WO1997036879A1 (en) | 1996-04-03 | 1997-10-09 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
US5859012A (en) | 1996-04-03 | 1999-01-12 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
US5852010A (en) | 1996-04-03 | 1998-12-22 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
US5965578A (en) | 1996-04-03 | 1999-10-12 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
US5869682A (en) | 1996-04-03 | 1999-02-09 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
US5885995A (en) | 1996-04-03 | 1999-03-23 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
AU707416B2 (en) | 1996-04-03 | 1999-07-08 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
AU715603B2 (en) | 1996-04-03 | 2000-02-03 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
US5891889A (en) | 1996-04-03 | 1999-04-06 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
CA2251955A1 (en) | 1996-04-18 | 1997-10-23 | Nancy E. Kohl | A method of treating cancer |
EP0934270A1 (en) | 1996-05-30 | 1999-08-11 | Merck & Co., Inc. | A method of treating cancer |
WO1998016523A2 (en) | 1996-10-11 | 1998-04-23 | Cor Therapeutics, Inc. | Selective factor xa inhibitors |
PL323130A1 (en) | 1996-11-15 | 1998-05-25 | Hoechst Ag | Application of heterocyclic compounds in production of a pharmaceutic agent, novel heterocyclic compounds and pharmaceutic agent as such |
WO1998022441A2 (en) | 1996-11-22 | 1998-05-28 | Elan Pharmaceuticals, Inc. | N-(aryl/heteroaryl) amino acid esters, pharmaceutical compositions, and methods for inhibiting beta-amyloid peptide and/or its synthesis |
TR199901132T2 (en) | 1996-11-22 | 1999-08-23 | Elan Pharmaceuticals, Inc. | To inhibit the release and/or synthesis of β-amyloid peptide using N-(aryl/heteoaryl) amino acid derivatives, pharmaceutical compositions containing them, and such compounds for methods. |
CN1237960A (en) | 1996-11-22 | 1999-12-08 | 伊兰药品公司 | N (aryl/heteroarylacetyl) amino acid esters, pharmaceutical compositions comprising same, and method for inhibiting 'beta'-amyloid peptide release and/or its synthesis by use of such compounds |
DE69733432T2 (en) | 1996-11-22 | 2006-05-04 | Elan Pharmaceuticals, Inc., San Francisco | N- (ARYL / HETEROARYL / ALKYL ACETYL) AMINO CREAM AMIDE, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS FOR INHIBITING BETA-AMYLOID PEPTIDE RELEASE OR SYNTHESIS |
TW523506B (en) | 1996-12-18 | 2003-03-11 | Ono Pharmaceutical Co | Sulfonamide or carbamide derivatives and drugs containing the same as active ingredients |
WO1998028980A1 (en) | 1996-12-30 | 1998-07-09 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
EP0968206B8 (en) | 1997-02-19 | 2007-01-24 | Berlex, Inc. | N-heterocyclic derivatives as nos inhibitors |
WO1998041510A1 (en) | 1997-03-14 | 1998-09-24 | Shionogi & Co., Ltd. | Novel benzolactam derivatives and medicinal compositions comprising the same |
EP0973396A4 (en) | 1997-04-07 | 2001-02-07 | Merck & Co Inc | A method of treating cancer |
US6060038A (en) | 1997-05-15 | 2000-05-09 | Merck & Co., Inc. | Radiolabeled farnesyl-protein transferase inhibitors |
DE19726427A1 (en) | 1997-06-23 | 1998-12-24 | Boehringer Mannheim Gmbh | Pyrimidine-2,4,6-trione derivatives, processes for their preparation and medicaments containing these compounds |
GB9715030D0 (en) | 1997-07-18 | 1997-09-24 | British Biotech Pharm | Metalloproteinase inhibitors |
CA2299610A1 (en) | 1997-08-11 | 1999-02-18 | Cor Therapeutics, Inc. | Selective factor xa inhibitors |
WO1999007730A1 (en) | 1997-08-11 | 1999-02-18 | Cor Therapeutics, Inc. | SELECTIVE FACTOR Xa INHIBITORS CONTAINING A FUSED AZEPINONE STRUCTURE |
CA2304473A1 (en) | 1997-09-29 | 1999-04-22 | Rajeev S. Bhide | Inhibitors of farnesyl protein transferase |
US6297239B1 (en) | 1997-10-08 | 2001-10-02 | Merck & Co., Inc. | Inhibitors of prenyl-protein transferase |
US6440965B1 (en) | 1997-10-15 | 2002-08-27 | Krenitsky Pharmaceuticals, Inc. | Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system |
IL159669A0 (en) | 1998-02-20 | 2004-06-01 | Deep Video Imaging Ltd | A multi-layer display for displaying images |
JP2002518481A (en) | 1998-06-22 | 2002-06-25 | エラン ファーマシューティカルズ,インコーポレイテッド | Compounds for inhibiting the release of β-amyloid peptide and / or its synthesis |
CA2324475A1 (en) | 1998-06-22 | 1999-12-29 | Elan Pharmaceuticals, Inc. | Cyclic amino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting .beta.-amyloid peptide release and/or its synthesis by use of such compounds |
AU5204799A (en) | 1998-06-22 | 2000-01-10 | Elan Pharmaceuticals, Inc. | Compounds for inhibiting beta-amyloid peptide release and/or its synthesis |
US6331408B1 (en) | 1998-11-12 | 2001-12-18 | Robert Zaczek | Use of small molecule radioligands to discover inhibitors of amyloid-beta peptide production |
US6525044B2 (en) | 2000-02-17 | 2003-02-25 | Bristol-Myers Squibb Company | Succinoylamino carbocycles and heterocycles as inhibitors of a-β protein production |
-
2001
- 2001-02-16 US US09/788,227 patent/US6525044B2/en not_active Expired - Lifetime
- 2001-02-16 AU AU2001239791A patent/AU2001239791A1/en not_active Abandoned
- 2001-02-16 EP EP01914400A patent/EP1261610A2/en not_active Withdrawn
- 2001-02-16 CA CA002395862A patent/CA2395862A1/en not_active Abandoned
- 2001-02-16 WO PCT/US2001/005236 patent/WO2001060826A2/en not_active Application Discontinuation
- 2001-02-16 JP JP2001560210A patent/JP2003523345A/en active Pending
Patent Citations (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5602156A (en) * | 1993-09-17 | 1997-02-11 | The United States Of America As Represented By The Department Of Health And Human Services | Method for inhibiting metalloproteinase expression |
US5770573A (en) * | 1993-12-06 | 1998-06-23 | Cytel Corporation | CS-1 peptidomimetics, compositions and methods of using the same |
WO1996029313A1 (en) * | 1995-03-21 | 1996-09-26 | The Procter & Gamble Company | Lactam-containing hydroxamic acid derivatives, their preparation and their use as inhibitors of matrix metalloprotease |
WO1997012861A1 (en) * | 1995-10-05 | 1997-04-10 | Chiroscience Limited | Mercaptoamide derivatives and their therapeutic use |
US5703129A (en) * | 1996-09-30 | 1997-12-30 | Bristol-Myers Squibb Company | 5-amino-6-cyclohexyl-4-hydroxy-hexanamide derivatives as inhibitors of β-amyloid protein production |
WO1998028268A2 (en) * | 1996-12-23 | 1998-07-02 | Elan Pharmaceuticals, Inc. | CYCLOALKYL, LACTAM, LACTONE AND RELATED COMPOUNDS AS β-AMYLOID PEPTIDE RELEASE INHIBITORS |
US5985900A (en) * | 1997-04-01 | 1999-11-16 | Agouron Pharmaceuticals, Inc. | Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses |
WO1999032453A1 (en) * | 1997-12-22 | 1999-07-01 | Elan Pharmaceuticals, Inc. | POLYCYCLIC α-AMINO-⊂-CAPROLACTAMS AND RELATED COMPOUNDS |
WO1999052889A1 (en) * | 1998-04-10 | 1999-10-21 | Pfizer Products Inc. | (4-arylsulfonylamino)-tetrahydropyran-4-carboxylic acid hydroxamides |
WO1999067221A1 (en) * | 1998-06-22 | 1999-12-29 | Elan Pharmaceuticals, Inc. | Compounds for inhibiting beta-amyloid peptide release and/or its synthesis |
WO2000002903A1 (en) * | 1998-07-10 | 2000-01-20 | Cytel Corporation | Cs-1 peptidomimetics, compositions and methods of using the same |
WO2000007995A1 (en) * | 1998-08-07 | 2000-02-17 | Du Pont Pharmaceuticals Company | SUCCINOYLAMINO LACTAMS AS INHIBITORS OF Aβ PROTEIN PRODUCTION |
WO2000038618A2 (en) * | 1998-12-24 | 2000-07-06 | Du Pont Pharmaceuticals Company | SUCCINOYLAMINO BENZODIAZEPINES AS INHIBITORS OF Aβ PROTEIN PRODUCTION |
Non-Patent Citations (1)
Title |
---|
SU SAN MOK ET AL: "A Novel Metalloprotease in Rat Brain cleaves ...", BIOCHEMISTRY, vol. 36, no. 1, 1997, pages 156 - 63, XP002177252 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9139520B2 (en) | 2007-12-21 | 2015-09-22 | Ligand Pharmaceuticals Incorporated | Selective androgen receptor modulators (SARMs) and uses thereof |
Also Published As
Publication number | Publication date |
---|---|
US20020055501A1 (en) | 2002-05-09 |
WO2001060826A2 (en) | 2001-08-23 |
CA2395862A1 (en) | 2001-08-23 |
US6525044B2 (en) | 2003-02-25 |
EP1261610A2 (en) | 2002-12-04 |
JP2003523345A (en) | 2003-08-05 |
AU2001239791A1 (en) | 2001-08-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2001060826A3 (en) | SUCCINOYLAMINO CARBOCYCLES AND HETEROCYCLES AS INHIBITORS OF Aβ PROTEIN PRODUCTION | |
WO2000038618A3 (en) | SUCCINOYLAMINO BENZODIAZEPINES AS INHIBITORS OF Aβ PROTEIN PRODUCTION | |
CA2379445A1 (en) | Lactams substituted by cyclic succinates as inhibitors of a.beta. protein production | |
TR200100377T2 (en) | Sucinoylamino lactams as Aß Protein production inhibitors. | |
CA2171882A1 (en) | Inhibitors of .beta.-amyloid protein production | |
WO2001019797A3 (en) | HYDROXYALKANOYL AMINOLACTAMS AND RELATED STRUCTURES AS INHIBITORS OF Aβ PROTEIN PRODUCTION | |
TW200502221A (en) | Novel lactams and uses thereof | |
WO2003027068A3 (en) | Substituted amines for the treatment of neurological disorders | |
MY138252A (en) | Azabicyclic-substitud fused-heteroaryl compounds for the treatment of disease | |
TW200420550A (en) | Thiazole compounds for the treatment of neurodegenerative disorders | |
ATE253918T1 (en) | USE OF HYMENIALDISINE AND ITS DERIVATIVES FOR THE PRODUCTION OF THERAPEUTIC AGENTS | |
NO20054120L (en) | Arylvinyl azacycloalkane compounds and processes for their preparation and use thereof | |
WO2007067511A3 (en) | Morpholine carboxamide prokineticin receptor antagonists | |
WO2006026204A3 (en) | Novel gamma-lactams as beta-secretase inhibitors | |
WO2003029169A3 (en) | Hydroxypropylamines | |
EA200601607A1 (en) | SULPHONAMIDE CONNECTIONS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS | |
WO2005003103A3 (en) | 2, 4, 6-tri-substituted 6-membered heterocycles and their use in the treatment of neurodegenerative diseases | |
WO2002100818A3 (en) | Aminediols as agents for the treatment of alzheimer's disease | |
WO2003070728A3 (en) | Azabicyclo-substituted benzoylamides and thioamides for treatment of cns-related disorders | |
WO2007034329A3 (en) | Compounds and methods for treatment of amyloid-beta-peptide related disorders | |
WO2005095348A3 (en) | Pyrazole-amine compounds for the treatment of neurodegenerative disorders | |
TW200504036A (en) | Novel lactams and uses thereof | |
WO2005016267A3 (en) | Oxazole compounds for the treatment of neurodegenerative disorders | |
WO2002094768A3 (en) | Aza hydroxylated ethyl amine compounds | |
MXPA04004771A (en) | Amine 1,2- and 1,3-diol compounds and their use for treatment of alzheimer's disease. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AU BR CA CN CZ EE HU IL IN JP KR LT LV MX NO NZ PL RO SG SI SK UA VN ZA |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AU BR CA CN CZ EE HU IL IN JP KR LT LV MX NO NZ PL RO SG SI SK UA VN ZA |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2395862 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001914400 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref country code: JP Ref document number: 2001 560210 Kind code of ref document: A Format of ref document f/p: F |
|
WWP | Wipo information: published in national office |
Ref document number: 2001914400 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2001914400 Country of ref document: EP |